Serum Levels of S100b and NSE Proteins in Patients with Non-Transfusion-Dependent Thalassemia as Biomarkers of Brain Ischemia and Cerebral Vasculopathy

Serum Levels of S100b and NSE Proteins in Patients with Non-Transfusion-Dependent Thalassemia as Biomarkers of Brain Ischemia and Cerebral Vasculopathy

Patients with non-transfusion-dependent thalassemia (NTDT) are at risk of developing brain ischemia. Transcranial Doppler (TCD) has been established as a useful screening tool of cerebrovascular disease in patients with sickle cell disease. Proteins neuron specific enolase (NSE) and S100B are biomar...

Full description

Bibliographic Details
Main Authors:	Aikaterini Kanavaki, Konstantinos Spengos, Maria Moraki, Polyxeni Delaporta, Catherine Kariyannis, Ioannis Papassotiriou, Antonis Kattamis
Format:	Article
Language:	English
Published:	MDPI AG 2017-12-01
Series:	International Journal of Molecular Sciences
Subjects:	non-transfusion-dependent thalassemia (NTDT) Transcranial Doppler (TCD) stroke silent infarct vasculopathy lactate dehydrogenase (LDH) neuron specific enolase (NSE) S100 calcium-binding protein B (S100B)
Online Access:	https://www.mdpi.com/1422-0067/18/12/2724

Similar Items

Beyond brain injury biomarkers: chemoattractants and circulating progenitor cells as biomarkers of endogenous rehabilitation effort in preterm neonates with encephalopathy
by: N. Efstathiou, et al.
Published: (2023-05-01)

The effect of obstructive sleep apnea syndrome on serum S100B and NSE levels: a systematic review and meta-analysis of observational studies
by: Farzad Rezaei, et al.
Published: (2020-02-01)

Increased Serum NSE and S100B Indicate Neuronal and Glial Alterations in Subjects Under 71 Years With Mild Neurocognitive Disorder/Mild Cognitive Impairment
by: Maryna Polyakova, et al.
Published: (2022-07-01)

Effects of early adjunctive pharmacotherapy on serum levels of brain injury biomarkers in patients with traumatic brain injury: a systematic review of randomized controlled studies
by: Noha O. Mansour, et al.
Published: (2023-05-01)

The Predictive Role of Neurobiochemical Markers in Multiple Sclerosis
by: Esra Fırat Oğuz, et al.
Published: (2020-01-01)

Heparin-Binding Protein (HBP), Neutrophil Gelatinase-Associated Lipocalin (NGAL) and S100 Calcium-Binding Protein B (S100B) Can Confirm Bacterial Meningitis and Inform Adequate Antibiotic Treatment
by: Maria Obreja, et al.
Published: (2022-06-01)

Serum inflammatory and brain injury biomarkers in COVID-19 patients admitted to intensive care unit: A pilot study
by: Stelios Kokkoris, et al.
Published: (2022-12-01)

Preventive citicoline administration is more eﬀective than therapeutic in model of transient cerebral ischemia in rats
by: G. Z. Sufianova, et al.
Published: (2019-06-01)

NEURODESTRUCTION OF HYPOTHALAMIC NUCLEI IN BRAIN INJURY. EFFECT OF CARBACETAM
by: S.V. Ziablitsev, et al.
Published: (2018-06-01)

Blood biomarkers in moderate-to-severe traumatic brain injury: potential utility of a multimarker approach in characterizing outcome
by: Alex P Di Battista, et al.
Published: (2015-05-01)

Comparison of Neuron-specific Enolase (NSE) Serum Level in Patients with Medullary Thyroid Carcinoma and Healthy individuals: Case-Control Study
by: Roghayeh Abbasalipourkabir, et al.
Published: (2022-01-01)

Value of NSE and S100 Protein of Kawasaki Disease with aseptic meningitis in Infant
by: Wang Jiangtao, et al.
Published: (2019-07-01)

Influence of carbacetam on neurologic destruction processes under the experimental traumatic brain injury
by: S. V. Ziablitsev, et al.
Published: (2017-02-01)

Influence of carbacetam on neurologic destruction processes under the experimental traumatic brain injury
by: S. V. Ziablitsev, et al.
Published: (2017-02-01)

Predictive Performance of Serum S100B Versus LDH in Melanoma Patients: A Systematic Review and Meta-Analysis
by: Eszter Anna Janka, et al.
Published: (2021-12-01)

Dynamics of neurospecific proteins content and their formation in experimental brain injury
by: S. V. Ziablitsev, et al.
Published: (2016-01-01)

Влияние карбацетама на процессы нейродеструкции в гиппокампе при экспериментальной черепно-мозговой травме.
by: S. V. Ziablitsev, et al.
Published: (2017-06-01)

Diagnostic Value of Serum Biomarkers for Differentiating Central and Peripheral Causes of Acute Vertigo
by: Jong-Hee Sohn, et al.
Published: (2020-03-01)

Elevated serum protein S100B and neuron specific enolase values as predictors of early neurological outcome after traumatic brain injury
by: Stefanović Branislava, et al.
Published: (2017-01-01)

Lack of association of S100β and neuron-specific enolase with mortality in critically ill patients
by: Roberta Candal de Macedo, et al.
Published: (2013-09-01)

Predictive Performance of Neuron-Specific Enolase (NSE) for Survival after Resuscitation from Cardiac Arrest: A Systematic Review and Meta-Analysis
by: Krzysztof Kurek, et al.
Published: (2023-12-01)

A Stress Syndrome Prototype Reflects Type 3 Diabetes and Ischemic Stroke Risk: The SABPA Study
by: Leoné Malan, et al.
Published: (2021-02-01)

Brain-Specific Biomarkers as Mortality Predictors after Aneurysmal Subarachnoid Haemorrhage
by: Jaroslaw Kedziora, et al.
Published: (2020-12-01)

Diagnostic Value of S100B and Neuron-specific Enolase in Distinguishing Acute Central and Peripheral Vertigo
by: Babak Masoumi, et al.
Published: (2022-12-01)

Neuron-Specific Enolase (NSE) as a Biomarker for Autistic Spectrum Disease (ASD)
by: Felician Stancioiu, et al.
Published: (2023-08-01)

Amino Acid Differences in the 1753-to-1851 Region of TcdB Influence Variations in TcdB1 and TcdB2 Cell Entry
by: Jonathan J. Hunt, et al.
Published: (2017-08-01)

Proinflammatory Cytokines, Enolase and S-100 as Early Biochemical Indicators of Hypoxic-Ischemic Encephalopathy Following Perinatal Asphyxia in Newborns
by: Verónica Chaparro-Huerta, et al.
Published: (2017-02-01)

Neuropeptide system parameters in acute herpes zoster
by: S. V. Knysh, et al.
Published: (2020-05-01)

Correlation between cerebral biomarkers and optic nerve sheath diameter in patients with severe preeclampsia
by: Gabrijela Brzan Simenc, et al.
Published: (2021-01-01)

Validity of neuron-specific enolase as a prognostic tool in acute ischemic stroke in adults at Suez Canal University Hospital
by: Mohammed H. Shash, et al.
Published: (2021-02-01)

Understanding the Intricacies of Iron Overload Associated with β-Thalassemia: A Comprehensive Review
by: Subhangi Basu, et al.
Published: (2023-07-01)

Comparing the dynamics of biomarkers of neuron-specific enolase and S-100 protein in neonates with hypoxic-ischemic encephalopathy, depending on the start of therapeutic hypothermia (0–6 h vs. 6–24 h after delivery)
by: D.M. Surkov
Published: (2019-03-01)

Serum Neuron-specific Enolase and S100 Calcium-binding Protein B in Pediatric Diabetic Ketoacidosis
by: Hatem Hamed Elshorbagy, et al.
Published: (2019-12-01)

Primary tumour category, site of metastasis, and baseline serum S100B and LDH are independent prognostic factors for survival in metastatic melanoma patients treated with anti-PD-1
by: Eszter Anna Janka, et al.
Published: (2023-08-01)

Specificity of Molecular Fragments Binding to S100B versus S100A1 as Identified by NMR and Site Identification by Ligand Competitive Saturation (SILCS)
by: Brianna D. Young, et al.
Published: (2021-01-01)

Distribution and Relative Abundance of S100 Proteins in the Brain of the APP23 Alzheimer’s Disease Model Mice
by: Simone Hagmeyer, et al.
Published: (2019-06-01)

The S100B Protein in Epilepsy
by: Ahmet Eren Seçen, et al.
Published: (2023-06-01)

Neuron-Specific Enolase and S100B: The Earliest Predictors of Poor Outcome in Cardiac Arrest
by: Robert Ryczek, et al.
Published: (2022-04-01)

The level of neuron-specific enolase and S-100 protein in the cerebrospinal fluid of patients with acute bacterial meningitis
by: A. V. Sokhan
Published: (2016-08-01)

The extent of damage following repeated injury to cultured hippocampal cells is dependent on the severity of insult and inter-injury interval
by: Jennifer E. Slemmer, et al.
Published: (2005-04-01)